Search

everythinglearnresearchcommunity

for

Search:↓

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

A complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide may help increase hair count in male pattern hair loss without side effects.

Androgens can both increase body hair and cause scalp hair loss.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Sunflower oil was found to promote hair growth in mice with hormone-induced hair loss.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Valproic acid helped hair growth in alopecia patient; more research needed.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Using a patient's own fat tissue helped treat hair loss caused by an injury.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Personalized treatments for hair loss are becoming more effective by using genetic information.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.